COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function (Q33678308)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function |
scientific article |
Statements
1 reference
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function (English)
1 reference
Joris D Veltman
1 reference
Margaretha E H Lambers
1 reference
Menno van Nimwegen
1 reference
Rudi W Hendriks
1 reference
Henk C Hoogsteden
1 reference
Joachim G J V Aerts
1 reference
Joost P J J Hegmans
1 reference
30 August 2010
1 reference
1 reference
1 reference
Identifiers
1 reference